Pancreatic Cancer Research

ResearcherNorthwestern UniversityActive in the last 2 years

Dhavan Shah

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7519-1065; OpenAlex author ID A5053195132, A5148325761. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper · 2026: 3 papers

Papers 5

  1. Mutant KRAS in Circulating Tumor DNA as a Biomarker in Localized Pancreatic Cancer Patients Treated With Neoadjuvant Chemotherapy. First author DOI 10.1097/sla.0000000000006562↗
  2. KRAS and TP53 Circulating Tumor DNA are Prognostic in Localized Pancreatic Cancer. Co-author DOI 10.1245/s10434-026-20447-0↗
  3. ASO Visual Abstract: KRAS and TP53 Circulating Tumor DNA are Prognostic in Localized Pancreatic Cancer Co-author DOI 10.1245/s10434-026-20549-9↗
  4. Prospective Evaluation of Circulating Tumor DNA Using Next-generation Sequencing as a Biomarker During Neoadjuvant Chemotherapy in Localized Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000006209↗
  5. Trametinib Potentiates Anti-PD-1 Efficacy in Tumors Established from Chemotherapy-Primed Pancreatic Cancer Cells. Co-author DOI 10.1158/1535-7163.mct-23-0833↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David J. Bentrem · 5 shared papers, 2024–2026 · strength 1.14
  2. M.C. Cox · 4 shared papers, 2025–2026 · strength 0.93
  3. Akhil Chawla · 4 shared papers, 2025–2026 · strength 0.93
  4. Dominic J. Vitello · 3 shared papers, 2026 · strength 0.70
  5. Alex Horowitz · 2 shared papers, 2026 · strength 0.47
  6. Krishay Sridalla · 2 shared papers, 2026 · strength 0.47
  7. Mario A. Shields · 1 shared paper, 2024 · strength 0.22
  8. Thao D. Pham · 1 shared paper, 2024 · strength 0.22
  9. Jeffrey H. Becker · 1 shared paper, 2024 · strength 0.22
  10. Hidayatullah G. Munshi · 1 shared paper, 2024 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.